Tom Duley joined Sidley Austin as a partner in its global Life Sciences practice.
Duley has extensive experience advising international and domestic clients in the life sciences sector on multifaceted strategic partnering and commercial transactions.
In addition to his experience serving clients as a partner in a multinational law firm, earlier in his career, Duley served as senior in-house corporate counsel at PDL BioPharma. He brings that operational experience to advising life sciences companies on key transactions such as multibillion-dollar collaboration agreements between biotechnology and pharmaceutical companies, as well as licensing agreements, supply and manufacturing agreements, and asset purchases and sales. He has counseled clients ranging from startup entities acquiring core technology rights from academic institutions to large public corporations in matters such as obtaining their first in-licensing agreement to the restructuring of their product holdings.
Duley’s experience also includes numerous cross-border transactions, including working with clients to develop and commercialize products in China. Additionally, he advises on intellectual property licenses, sponsored research agreements, co-promotion and material transfer agreements, as well as litigation settlements, M&A and capital markets transactions.
“Tom’s addition is confirmation of Sidley’s ongoing commitment to delivering the full spectrum of services to clients in the life sciences space,” said Sharon Flanagan, partner and member of the firm’s Executive Committee.
